(Q48921641)

16 February 2018

title

Mdm2 and the p53 pathway in human pituitary adenomas. (English)

1 reference

16 February 2018

author name string

M Suliman

1

1 reference

16 February 2018

J Royds

2

1 reference

16 February 2018

D Cullen

3

1 reference

16 February 2018

W Timperley

4

1 reference

16 February 2018

T Powell

5

1 reference

16 February 2018

R Battersby

6

1 reference

16 February 2018

T H Jones

7

1 reference

16 February 2018

publication date

1 March 2001

1 reference

16 February 2018

published in

Clinical Endocrinology

1 reference

16 February 2018

volume

54

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

page(s)

317-325

1 reference

16 February 2018

Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Cytokine expression in human anterior pituitary adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Clonal origin of pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Molecular analysis of p21 and p27 genes in human pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Growth rate of human pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

p53 gene mutations in pituitary adenomas: rare events

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Amplification of a gene encoding a p53-associated protein in human sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Isolation and characterization of a pituitary tumor-transforming gene (PTTG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Why is p53 protein stabilized in neoplasia? Some answers but many more questions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

IL-8 mRNA expression by in situ hybridisation in human pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Are markers of proliferation valuable in the histological assessment of pituitary tumours?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

The influence of cell context on the selection pressure for p53 mutation in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

Immunohistochemical study of p53 protein in human and animal pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01195.X

10.1046/J.1365-2265.2001.01195.X

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018